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We have used the polymerase chain reaction (PCR) to synthesise a cDNA encoding part of human cardiac troponin I. Amplification was achieved 
using fully degenerate sets of oligonucleotides corresponding to conserved regions of amino acid sequence identified in other troponin I isofonns. 
The cloned PCR fragment was subsequently used to isolate full-length cDNAs from a cardiac cDNA library. We describe the approach, as a general 
cloning strategy starting from limited amino-acid sequence data and report the cloning, and complete amino acid sequence of human cardiac tropon- 
in I. Analysis of human development using these clones demonstrates early expression of this gene in the heart. 
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1. INTRODUCTION 
Troponins I, T and C are a group of muscle-specific 
myofibrillar proteins which are involved in regulating 
the interaction of actin and myosin. Three isoforms of 
troponin I (Tnl) have been identified and are present as 
the major isoforms in cardiac muscle (Tnlc), slow 
skeletal muscle (Tnls) and fast skeletal muscle (Tnlf). 
The available amino acid sequence data for these three 
isoforms, from bovine, rabbit and chick muscle [l-4], 
show that they are encoded by separate genes. The car- 
diac isoform differs from those found in skeletal muscle 
in that it has an extended N-terminal sequence. This N- 
terminal region contains a serine residue which is 
phosphorylated during the phosphorylation-mediated 
regulation of contraction by P-adrenergic agonists in 
the heart [5]. 
interested in the regulation of troponin I gene expres- 
sion in the heart, and have undertaken to clone human 
cardiac troponin I. To date, no amino-acid sequence 
data have been available for the human Tnlc isoform. 
We have made use of amino acid sequence data from 
other-species, and from other isoforms of Tnl, in order 
to predict the human Tnlc sequence, and have used the 
polymerase chain reaction (PCR) in order to amplify 
corresponding human cardiac cDNA sequences. In this 
way we generated a partial cDNA clone which was 
subsequently used to isolate full length cDNAs from a 
human cardiac library. Here we report the approach us- 
ed for cloning the cDNA, of general use in cloning from 
limited amino-acid sequence data, and present he com- 
plete amino acid sequence of the human cardiac 
troponin I isoform. 
Antibody studies in rat and chick have demonstrated 
that there is a switch in Tnl isoform expression during 
cardiac development, and suggest that the major 
isoform in early fetal heart is Tnls, and that this is 
replaced by Tnlc late in fetal development [6,7]. We are 
2. MATERIALS AND METHODS 
2.1, Oligonucleotide primers 
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Abbreviations: TnI, troponin I (TnIc, TnIf and TnIs; cardiac, fast 
skeletal and slow skeletal muscle isoforms, respectively); PCR, 
polymerase chain reaction; SDS, sodium dodecyl sulphate; BSA, 
bovine serum albumin, bp, base pairs 
The nucleotide sequence reported here has been submitted to the Gen- 
Bank/EMBL Data Bank with accession number X54163 
Fully degenerate sets of oligonucleotide primers (oligo-sets), com- 
plementary to three regions that are 100% conserved between the 
published troponin I amino acid sequences [l-4] (see Fig. 2), were 
synthesized and used to prime PCR reactions. Set 1 (a sense strand 
22-mer, with 128-fold degeneracy) corresponds to amino acid residues 
136 to 140 (RGKFK). Set 2 (antisense strand 27-mer, with 64-fold 
degeneracy) corresponding to amino acids 179-184 (EDTEKE). Set 3 
(antisense 22-mer, with 64-fold degeneracy) corresponding to amino 
acids 201-205 (MEGRK). Each set carries additional nucleotides 
(underlined) including PstI or EcoRI restriction sites. Dgenerate posi- 
tions are indicated in parentheses. 
Set 1:s ’ -ATCTGCAG(C/A)G(T/C/G/A)GG(T/C/G/A)AA(G/A)- 
TT(T/C)AA-3 ’ 
Set 2:5’-CGCGGAATTCTC(T/C)TT(T/C)TC(T/C/G/A)GT(A/G)- 
TC(T/C)TC-3 
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5'-CTGAAGGTCACCCGGGCGGC 
CCCCTCACTGACCCTCCAAACGCCCCTGTCCTCGCCCTGCCTCCTGCCATTCCCGGCCTG 
MetAlaAspGlySerSerAspAlaAlaArgGluProArgProAlaProAla 
AGTCTCAGCATGGCGGATGaGAGCAGCGATGCGGCTA~GGMCCTCGCCCTGCACCA~CC 
ProIleArgArgArgSerSerAsnTyrArgAlaTyrAlaThrGluProHisAlaLysLys 
CCMTCAGACOCCGCTCCTCCM~ACCGCGCTTATGCCACGGAGCCGCACGCCMG~ 
LysSerLysIleSerAlaSerArglysLeuGlnLeulysThrLeuLeuLeuGlnIleAla 
~TCTMGATCTCCOCCTCGAG~TT~AGCT~GACTCTGCTGCTGCAGATTGCA 
LysGlnGluLeuGluArgGluAlaGluGluArgArgGlyGluLysGlyArgAlaLeuSer 
MGCMGAGCTGGAGCGAGAGGCGGAGGAGCGGCGCGGAGAGMGGGGCGCGCTCTGAGC 
ThrArgCysGlnProLeuGluLeuThrGlyLeuGlyPheAlaGluLeuGlnAspLeuCys 
ACCCGCTGCCAGCCGCTGGAGTTGACCGGGCTGGGCTTCGCGGAGCTGCAGGACTTGTGC 
ValThrLysAsnIleThrGluIleAlaAspLeuThrGlnLysIlePheAspLeuArgGly 
GTCACCMG~CA~ACGHJAOATTGCAGATCTGACTCAGMGATCTTTGACCTTCGA~ 
LeuLeuGlyAlaArgAlaLysGluserLeuAspLeuArgAlaHisLeuLysGlnValLys 
CTGCTGGGGGCCCGGGCTAAGGAGTCCCTGGACCTGCGGGCCCACCTCMGCAG~TG~G 
LeuSerGlyMetGluGlyArgLysLysLysPheGluSer*** 
CTOllQTQO~TGGAGGK3CCGCMG~GTTTGAGAGCTGAGCCTTCCTGCCTACTGCC 
CCTGCCCTGAGGAGGGCCACTGAGGAATAAAGCTTCTCTCTGAGCTG- 
Fig. 1. Nucleotide sequence of clone pCTI-2 and deduced amino acid sequence of human cardiac troponin I. Under~ned (from 5 ’ to 3 ’ ) are the 
translation initiation consensus equence 1141, the positions of oiigo-sets 1, 2 and 3 (see text), and the poly-adenylation signal sequence [121. 
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Set 3:5’-ATGAATTCTT(T/C/G/A)C(T/G)(T/C/G/A)CC(C/T)- 
TCCAT3 ’ 
2.2. cDNA synthesis and polymerase chain reactions 
cDNA synthesis was carried out as follows: 50 pmol of oligo-set 3 
was annealed with 1 pg of human ventricular muscle RNA in 20 ~1 of 
Hz0 by heating to 65’C and cooling slowly to 20°C. Extension was 
carried out in 10 mM Tris-HCl (pH 8.4) 50 mM KCI, 1.5 mM MgC12, 
100 @ml BSA, 150 mM each of dATP dCTP dGTP and dTTP, 10 
mM DTT, 0.2 units/~ RNase inhibitor (Amersham) and 15 units 
AMV reverse transcriptase (Pharmacia) at 42’C for 1 h. Polymerase 
chain reactions were carried out in the same buffer by the addition of 
appropriate oligo-sets (50 pmol) and 1 unit Taq polymerase (United 
States Biochemical). 40 cycles were carried out for 1 .S min at 94”C, 
2 min at 50°C and 2 min at 72”C, followed by a final 10 min extension 
at 72°C. 
[H] MADGSSDA*.AREPRPAPAPIRRRSS*NYRAYA 
[H] --R~GGST~GDTV---P-V~-~~~A~~~~~~ 
[R] --E~R-~~~G~A~~---~V--~~~~D~~~~~ 
[H] DWRKNIDALSGME KKFES 
[B] -________--__"""____G 
[R] ~~~~~~~L~~~~~~~~~~~~G 
[RSJ-----VE-M--------M-DAAKSPTSQ 
[RF]~~~~~~EEK~~~~~~~~M~~~ES 
30 
62 
94 
126 
158 
189 
Fig. 2. Alignment of the human cardiac troponin I sequence with other published sequences [see 11. Single letter code has been used; (N) = identical 
amino acid, (*) = no corresponding amino acid. Underlined are the amino acid sequences used in generating oligo-sets 1, 2 and 3 (see text). 
Numbering refers to the human sequence only. 
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2.3. Isolation of full length cDNAs and sequence analysis 
cDNA clones encoding cardiac troponin I were isolated from a 
human ventricular cDNA library cloned in Lambda ZAP11 
(Stratagene Inc) using insert DNA from a PCR-derived clone 
(pCTI-I), and standard screening methods [8]. Isolated phages were 
converted to pBluescript plasmid by Lambda ZAP11 excision in vivo. 
7 independent clones were analysed for insert size and two were 
selected for sequence analysis. DNA sequencing was carried on both 
DNA strands by the dideoxy chain-termination method using addi- 
tional oligonucleotide primers synthesised for internal sequences. 
2.4. RNA preparation and Northern blot analysis 
RNA was prepared from cardiac muscle obtained from therapeutic 
abortions, autopsy samples and transplant material, using isothio- 
cyanate and CsCl centrifugation [9]. Northern blots were prepared us- 
ing 10 pg of total RNA run on 1% agarose-formaldehyde g ls [8] and 
transferred in alkali to Hybond N + membranes (Amersham UK). “P 
labelled probes were prepared by random priming [8] of insert DNA 
from clone pCTI-3. 
3. RESULTS AND DISCUSSION 
PCR amplification of single stranded cDNA 
(prepared from human ventricular muscle RNA) with 
primers 1 and 3 resulted in a single 225bp DNA frag- 
ment - the size predicted for TnIc (data not shown). 
The identity of this fragment was further confirmed by 
re-amplification of the DNA fragment using primers 1 
and 2. This resulted in the expected size change from 
225 bp to 164 bp (data not shown). This fragment was 
subcloned into pBluescript (Stratagene Inc) after diges- 
tion with EcoRI and PstI, and the sequence of the 
resulting clone (pCTI-1) confirmed its identity with 
TnIc. Due to an internal Pstl site in the PCR fragment, 
clone pCTI-1 in fact contains a 113 bp insert including 
sequence corresponding to amino acids 151-184. 
The use of the polymerase chain reaction to clone 
cDNAs from poorly defined amino-acid sequence data 
is clearly of major importance [IO]. We have taken the 
approach of using fully degenerate oligonucleotide sets 
(e.g. [ll]) covering all possible coding sequences cor- 
responding to conserved protein domains. One poten- 
tial disadvantage of this method is that it increases the 
chances of amplifying unrelated sequences. In our ex- 
perience this is overruled by the certainty of including 
the exact oligonucleotides required for successful 
amplification. In addition, the use of internal primers 
represents arapid and convenient approach to confirm- 
ing the identity of amplified products. 
Screening of a human cardiac cDNA library with the 
DNA insert from pCTI-1 identified 7 independent 
hybridizing clones, two of which were fully sequenced. 
Fig. 1 shows the sequence of clone pCTI-2 which con- 
tains the entire coding sequence of human TnIc. The 
identity of this clone is confirmed both by comparison 
with amino acid sequences of other troponin I isoforms 
(Fig. 2) and by Nothern blot hybridization (Fig. 3). This 
clone contains the poly-adenylation signal (AATAAA 
[12]) and a poly-A tail of 33 nucleotides indicating that 
it contains the entire 3’ non-coding sequence. Clone 
pCTI-3 was found to contain sequences from amino 
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Fig. 3. Northern blot hybridization of ventricular muscle RNA from 
20 week fetal heart (track l), 28 week fetal heart (track 2), 9 month 
postnatal heart (track 3), adult ventricular muscle (track 4). and adult 
skeletal (quadriceps) muscle (track 5). Following hybridization, filters 
were washed in 0.1 x SSC, 0.1% SDS at 65°C. The positions of RNA 
size markers are indicated in thousands of nucleotides. 
acid 77 to the end of the 3 ’ non-coding sequence but not 
including any poly-A tail. The amino acid sequence 
derived from these clones is shown in Fig. 1. The three 
published cardiac sequences were aligned as shown in 
Fig. 2, where they are contrasted to the fast and slow 
skeletal isoforms of rabbit [4]. Alignment of the cardiac 
sequences shows that they are highly conserved 
throughout their length with the exception of the N- 
terminal sequence. This is of particular interest con- 
sidering that the N-terminal sequence is involved in the 
phosphorylation-mediated response to .&adrenergic 
agonists [5]. Manipulation of the troponin I sequence 
by the use of site directed mutagenesis hould allow a 
more detailed analysis of the functional importance of 
this and other domains. 
During development of the rat and chick heart, there 
is a transition from expression of TnIs to that of TnIc 
late in fetal life [6,7]. We have used our cloned cDNA 
to examine the expression of TnIc in the developing 
human heart. Fig. 3 shows that the adult cardiac 
isoform already represents a major transcript by 20 
weeks gestation. No cross-hybridisation with skeletal 
muscle troponin I mRNA, present in RNA from 
quadriceps, is detected in this experiment (track 5, Fig. 
3) indicating the specificity of the probe used. This 
result is consistent with previous reports using an- 
tibodies which detected TnIc as the major isoform at 20 
weeks [14], but contrasts with the rat and chick where 
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transition from TnIs to TnIc occurs around the time of 
birth. Our data imply that if there is a transition TnI ex- 
pression in the human myocardium which is com- 
parable to that seen in rat and chick, it must occur 
before 20 weeks. Further developmental studies using 
cloned probes should allow us to determine the exact 
timing of activation of this gene. 
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